Myelodysplastic syndromes trials in China

In China 53 Also abroad 369

53 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
National Longitudinal Cohort of Hematological Diseases
Where
Tianjin
People
2,300
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT04645199
Phase 1Taking people
Romiplostim N01 for Platelet Recovery After Haploidentical HSCT
Where
Hangzhou
Age
18 years and over
People
130
Run by
First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07321626
Phase 1Taking people
A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies
Where
Nanchang, Tianjin, Wuhan
Age
18 years to 75 years
People
45
Run by
Cullgen (Shanghai),Inc
See details and how to joinNCT07347171
No phaseTaking people
Safety and Feasibility of Sulforaphane to Promote Early Haematopoietic Recovery After Cord Blood Transplantation
Where
Tianjing
Age
18 years and over
People
36
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07297576
No phaseEnrolling by invitation
Follow-up Study of ICUS and CCUS Patients
Where
Suzhou
Age
18 years and over
People
300
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT04428489
No phaseTaking people
High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
Where
Xining
People
1,000
Run by
Yigeng Cao,MD,PhD
See details and how to joinNCT07205523
Phase 2Taking people
Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients
Where
Beijin, Chengdu, Jinan, Shijia Zhuang, Zhengzhou
Age
18 years and over
People
236
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06918834
Phase 1Taking people
A Study of GLB-001 in Patients With Myeloid Malignancies
Where
Beijing, Chongqing, Hangzhou, Hefei, Nanchang, Shanghai, Shenyang, Shijiazhuang, Suzhou, Tianjin, Wenzhou, Wuhan, Zhengzhou
Age
18 years and over
People
108
Run by
Hangzhou GluBio Pharmaceutical Co., Ltd.
See details and how to joinNCT06378437
Phase 2Taking people
Clinical Study of Venetoclax Combined With Azacitidine as Bridging Therapy Prior to Hematopoietic Stem Cell Transplantation in Patients With Higher-Risk Myelodysplastic Syndromes
Where
Changchun
Age
18 years and over
People
46
Run by
Yehui Tan
See details and how to joinNCT07047183
Phase 2Taking people
Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT
Where
Beijing
Age
12 years to 65 years
People
40
Run by
Peking University People's Hospital
See details and how to joinNCT06984536
Phase 2Not yet taking people in China
Reduced Intensity Conditioning for MDS
Where
Shanghai
Age
14 years to 70 years
People
45
Run by
Ruijin Hospital
See details and how to joinNCT07085156
Phase 2Taking people
Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT
Where
Beijing
Age
12 years to 65 years
People
35
Run by
Peking University People's Hospital
See details and how to joinNCT06130579
Phase 2/3Taking people
Molecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation
Where
Shanghai
Age
14 years to 75 years
People
126
Run by
Ruijin Hospital
See details and how to joinNCT06972641
Phase 2Not yet taking people in China
Selinexor Combined With Azacitidine Therapy in High-Risk Myeloid Neoplasms Patients
Where
Tianjin
Age
16 years to 75 years
People
20
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06900088
Phase 3Taking people
Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies
Where
Fuzhou, Kunming, Nanjin, Nanning, Shanghai, Suzhou, Xiamen
Age
16 years to 55 years
People
222
Run by
Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT05991908
Phase 3Taking people
Conditioning Regimen of Melphalan-busulfan and Fludarabine: a Randomized Study of Different Dose of Melphalan
Where
Shanghai
Age
18 years to 55 years
People
120
Run by
Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06829472
Phase 2Taking people
A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes
Where
Tianjin
Age
18 years and over
People
90 worldwide
Run by
Akeso
See details and how to joinNCT06196203
Phase 2Not yet taking people in China
Selinexor Combined With Venetoclax Maintenance Therapy After Allo-HSCT
Where
Shanghai
Age
18 years to 75 years
People
73
Run by
Ruijin Hospital
See details and how to joinNCT06765928
Phase 2Taking people
Prophylactic Intervention for Relapse Prevention Post-Allogeneic Transplantation in Very High-Risk MDS Patients Based on IPSS-M Stratification
Where
Shanghai
Age
18 years to 70 years
People
40
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06612944
Phase 1/2Taking people
VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS
Where
Beijing
Age
70 years and over
People
54
Run by
Navy General Hospital, Beijing
See details and how to joinNCT06471946
No phaseTaking people
Clinical Registration Study of Haplo-HSCT for Elderly Patients With Acute Leukemia/ Myelodysplastic Syndrome
Where
Beijing
Age
55 years to 70 years
People
120
Run by
Peking University People's Hospital
See details and how to joinNCT05902416
Phase 1Taking people
A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies
Where
Beijing, Chengdu, Harbin, Shanghai, Shijiazhuang, Tianjin
Age
18 years and over
People
100
Run by
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT06550713
Phase 2Taking people
VA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDS
Where
Beijing
Age
18 years to 70 years
People
67
Run by
Beijing 302 Hospital
See details and how to joinNCT06536959
No phaseTaking people
Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement
Where
Shanghai
Age
18 years to 55 years
People
50
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06111612
Phase 1/2Taking people
TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies
Where
Tianjin
Age
18 years and over
People
30
Run by
Shenzhen TargetRx Co., Ltd.
See details and how to joinNCT06206174